RxDoctor Payments Data

Sidney Griffith, MD

Family Medicine · Cape Girardeau, MONPI 1285628867

Payments from drug & device makers

$11,945in general payments, 2019–2025

Across 754 payments — averaging $15.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Lilly USA, LLC$829
  • Novo Nordisk$615
  • AstraZeneca$478
  • Amgen$470
  • Boehringer Ingelheim$438
  • plus $5K from 42 others

What the payments were for

  • Food & beverage$11,934100%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$11,945 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$469,425
Medicare patients
960
Services billed
14,272

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide225$232,789
EliquisApixaban161$117,351
XareltoRivaroxaban136$106,728
JardianceEmpagliflozin91$75,515
JanuviaSitagliptin Phosphate48$38,610
FarxigaDapagliflozin Propanediol45$37,547
Trelegy ElliptaFluticasone/Umeclidin/Vilanter50$32,429
ArexvyRsvpref3 Antigen/As01e/Pf79$21,683
MounjaroTirzepatide21$21,666
TradjentaLinagliptin32$21,251
Breztri AerosphereBudesonide/Glycopyr/Formoterol25$15,860
TrulicityDulaglutide13$15,731
MyrbetriqMirabegron16$15,317
Tresiba Flextouch U-200Insulin Degludec12$14,997
Pantoprazole Sodium556$10,528

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$615$232,789225 claims
PfizerEliquis, Premarin$283$120,545175 claims
Johnson & JohnsonXarelto$413$106,728136 claims
Boehringer IngelheimJardiance, Tradjenta$438$96,765123 claims
GSKTrelegy Ellipta, Arexvy, Breo Ellipta$358$60,129144 claims
AstraZenecaFarxiga, Breztri Aerosphere$478$53,40770 claims
MerckJanuvia, Janumet Xr, Dulera$217$48,38271 claims
Lilly USA, LLCMounjaro, Trulicity$829$37,39734 claims
AbbVieSynthroid, Namzaric, Linzess$4,373$20,159155 claims
Astellas Pharma US IncMyrbetriq$436$15,31716 claims
Sumitomo Pharma America, Inc.Gemtesa$196$9,26919 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$49$5,51011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Cape Girardeau

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →